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This manuscript considers the central but neglected role of the autonomic nervous
system in the expression and control of seizures in epilepsy (small) and tics in Tourette
Syndrome (TS). In epilepsy, consideration of autonomic involvement is typically confined
to differential diagnoses (e.g., syncope), or in relation to Sudden Unexpected Death in
Epilepsy (SUDEP). Investigation is more limited in Tourette Syndrome. The role of the
autonomic nervous system in the generation and prevention of epileptic seizures is largely
overlooked. Emotional stimuli such as anxiety and stress are potent causes of seizures
and tic activity in epilepsy and TS, respectively. This manuscript will describe a possible
neural mechanism by which afferent autonomic projections linked to cognition and
behavior influence central thalamo-cortical regulation, which appears to be an important
means for controlling both seizure and tic activity. It also summarizes the link between the
integrity of the default mode network and autonomic regulation in patients with epilepsy
as well as the link between impaired motor control and autonomic regulation in patients
with TS. Two neurological conditions; epilepsy and TS were chosen, as seizures and tics
represent parameters that can be easily measured to investigate influences of autonomic
functions. The EDA biofeedback approach is anticipated to gain a strong position within
the next generation of treatment for epilepsy, as a non-invasive technique with minimal
side effects. This approach also takes advantage of the current practical opportunity to
utilize growing digital health technology.
Keywords: biofeedback, electrodermal activity, sympathetic activity, behavioral control, epilepsy, Tourette
Syndrome
Introduction
Penfield and Jasper (1954) observed autonomic responses to cerebral stimulation in humans
undergoing epilepsy surgery under local anesthesia. Different cortical and subcortical sites of
stimulation engendered a range of autonomic changes, suggesting that epileptic foci can also
differentially influence autonomic activity. Correspondingly, focal discharges in the temporal and
frontal cortices could result in autonomic disturbances affecting arterial blood pressure, heart
rate and rhythm, and cardiac neural discharge. Animal studies demonstrated that even minimal
epileptogenic activity (single spikes) can alter cardiac neural discharges and arrhythmias (Schraeder
andCelesia, 1977). It is also noteworthy that patients with epilepsy, compared with healthy controls,
show interictal autonomic abnormalities (in electrodermal activity and heart rate variability; HRV)
(Drake et al., 1998; Zaatreh et al., 2003; Berilgen et al., 2004; Evrengül et al., 2005). Specifically,
Nagai Autonomic function and neurological conditions
patients with epilepsy, compared with healthy controls have
significantly higher amplitude and latency of sympathetic
skin response, and consistently lower HRV (an index of
vagal parasympathetic tone). The reduced HRV and impaired
baroreflex sensitivity may decrease the threshold of the body’s
capacity to cope physiologically with seizure events (Surges
et al., 2009). Sudden unexpected death associated with epilepsy
(SUDEP) may be a key consequence of epilepsy-associated
autonomic dysfunction (Nashef et al., 1998; Surges et al.,
2009). In epilepsy and other neurological and neuropsychiatric
disorders such as Tourette Syndrome, patients frequently report
that emotional stress, (which typically results in enhanced
sympathetic and reduced cardiac parasympathetic activity)
triggers an exacerbation of symptoms (Antebi and Bird, 1993;
Spector et al., 2001; Steinberg et al., 2013a,b). Moreover, some
patients with epilepsy are able to suppress or terminate seizures
by developing behavioral “countermeasures” that depend on
intentional regulation of autonomic arousal (Fenwick, 1991).
Together, these observations highlight the bidirectional coupling
of central epileptogenesis with autonomic regulation wherein
seizure activity can provoke potentially pathological autonomic
change. On the other hand the state of peripheral autonomic
arousal also impacts on seizures occurrence. This coupling may
also add a psychophysiological dimension to epilepsy control
by neural systems controlling emotional and bodily arousal
influence seizure thresholds.
The current manuscript will present a perspective on the
autonomic involvement in the generation and suppression of
symptoms of two neurological conditions, epilepsy and Tourette
Syndrome. These neurological conditions are the focus of the
current manuscript, since the occurrence of seizures and tics
are explicit measures of clinical outcome on which we can
evaluate the effects of autonomic function and its modulation. A
model will be discussed regarding the mechanisms of interaction
between emotional triggers, autonomic regulation, and the
expression of both seizures and tics.
Emotional Triggers of Seizures and Tics
Epilepsy is the most common serious neurological disorder,
affecting 0.5–1% of the population worldwide. The prognosis
of intractable epilepsy has not been changed significantly by
the recent introduction of new antiepileptic drugs; one third of
patients with epilepsy do not become seizure-free and therefore
carry an increased risk ofmorbidity andmortality (Hopkins et al.,
1995). Epilepsy is a neural disease classified into three types based
on broad underlying mechanisms: genetic, structural/metabolic,
and unknown cause (Noebels et al., 2002). The majority of
genetic causes of epilepsy entail mutations in genes encoding
ion channels resulting in altered neural function in the central
nervous system (Noebels et al., 2002). These may well also affect
metabolic functions and these same mutations very likely alter
autonomic nervous system function. Tourette Syndrome is a
neuropsychiatric disorder of developmental origin, characterized
by involuntary motor and phonic tics. Prevalence is reported
as up to 1 in 100 school children with one third of patients
continuing to express significant symptoms into adulthood
(Robertson, 2000). There is general agreement that TS is strongly
genetic (Robertson, 2000). Studies of twins demonstrate the
heritable expression of the condition, with rates significantly
higher in monozygotic twin pairs (77%) compared to dizygotic
twins (23%) (Price et al., 1985).
In epilepsy, it is generally considered that seizure occurrence
in patients take place randomly without any apparent causes.
Patients are often insecure due to the unpredictability of the
occurrence of their seizures and this can markedly limit patients’
social activities. However, there is much evidence that patients’
seizures are often linked to fluctuations in emotional, mental
and physiological states in their daily life, and that anxiety is
a common trigger of seizures (Fenwick, 1991; Antebi and Bird,
1993; Spector et al., 2001; Nakken et al., 2005; Petitmengin
et al., 2006; Pinikahana and Dono, 2009). This association
was acknowledged well over a century ago. Gowers (1885)
described, “Of all the immediate causes of seizures, the most
potent are psychical-fright, excitement, and anxiety,” However,
this observation has not been the focus of much scientific
investigation until relatively recently. A questionnaire study of
100 patients with epilepsy from an outpatients clinic (seizure
type: 56% multiple, 51% partial, 24% partial with secondary
generalization and 20% generalized) found that negative mental
states were a potent cause of seizures: Tension and anxiety
was reported to trigger seizure occurrence and increase seizure
frequency in 66% of patients, unhappiness and depression in
44%, and overexcitement in 38% of patients. Interestingly,
92% of patients were also able to recognize states that could
either trigger or suppress their seizures (Antebi and Bird,
1993). Extending this finding, up to 25% of patients reported
that they were actually able to induce a seizure by their own
will, and most of these patients also had their own strategy
(ex destraction of attention, clenching fist) to suppress their
seizures (Fenwick, 1991). Another questionnaire survey of 100
epilepsy patients reported that a significant percentage (over
90%) can identify high-risk (trigger) situations, typically states of
heightened stress/tension and anxiety. Low risk (safe) situations,
on the other hand, seemed to be more difficult to recognize.
Patients identified low risk situations as being times when they
were relaxed, not feeling stressed, feeling restful, not worried
(55.4%), mentally occupied, concentrating, being busy (29.2%),
being happy (18.5%), and when not tired (7.7%) (Spector et al.,
2001). These studies were replicated in larger clinical samples
(309 and to 1677 patients) and strongly linking emotional
stress, tiredness and sleep deprivation to seizure occurrence,
consolidated evidence that emotional, mental and physiological
states influence the expression of epilepsy (Nakken et al., 2005;
Pinikahana and Dono, 2009).
An increase in the number and intensity of tics in patients with
Tourette Syndrome when discussing sensitive topics or during
states of physical arousal associated with significant emotional
disturbance has been observed in patients (Clinical observation,
if not in majority of patients). There is likely also an interaction
with affective instability and related behavioral problems, since
comorbid neuropsychiatric symptoms such as attention deficit
hyperactivity disorder (ADHD), Autism Spectrum Disorder
(ASD), mood disorder and obsessive compulsive disorder (OCD)
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are common (Hoekstra et al., 2013). One study used video
clips to induce emotional changes in Tourette patients (Wood
et al., 2003). Here, increased tics were observed during the
anticipation, low-grade experience and resolution of emotional
changes (Wood et al., 2003). Interestingly, fewer tics were
observed during situations eliciting anger and happiness. It is
reported that the intensity of concentration/attention associated
with high emotional engagement may be responsible for this
reduction, however further work is needed to better understand
biological mechanisms as the sample size (n = 4) of the study
was small (Wood et al., 2003). The psychological influence on the
expression of tics is apparent in that the intensity of tics (or the
urge to tic) is strongly influenced by a patient’s belief about tics
(Steinberg et al., 2013a). The self-report inventory of premonitory
urges for tics was highly correlated with scale of beliefs about tic
(Steinberg et al., 2013a). Tic activity is also related to stressful
events occurring in daily life (Steinberg et al., 2013b).
Despite the recognition that emotional triggers influence
symptom expression, the pathological mechanisms by which
emotional arousal and autonomic disturbance act on neural
substrates responsible for triggering of either seizures or tics
are poorly understood. Behavioral effects on the seizure focus
were demonstrated in non-human primates using the almina-
gel model of epilepsy (Lockard and Wyler, 1979). Wyler et al.
(1975) identified two types of neural composition surrounding
a seizure focus: Group 1 neurons, are highly epileptogenic
and constantly fire in neural clusters. This class of neuron
shows non-attenuation of bursting neural activity during the
operant condition (increased attention). Surrounding these are
the group 2 neurons, which contain both epileptogenic and
non-epileptogenic neurons. Thus Group 2 neurons are less
epileptogenic overall. Interestingly, operant conditioning can
reduce single cell firing in group 2 neurons. The normal
neurons within the group 2 class are engaged by experimental
enhancement of attention, and also during feeding times. These
changes were related to a reduction in ictal events, suggesting
the experimental manipulations prevented the recruitment of
surrounding non-epileptogenic neurons into the spreading ictal
focus. It is important to note that the manifestation of seizures
in humans is not as simple as is suggested by the above
animal models. Seizure activity is influenced in a number of
distinct ways, including dependence on the site of seizure origin
and intrinsic circuits supporting local seizure spread, and the
extension of aberrant activity into motor regions to influence
motor excitability and associated movements (Miller, 1992).
Moreover in humans, emotional triggers may putatively interact
with the epileptic focus via feedback of autonomic arousal,
conveyed centrally by visceral afferent inputs.
Autonomic Activity in Epilepsy and
Tourette Syndrome
Autonomic activity is intrinsically linked to our emotional,
mental, and physiological state. Emotional disturbances
are accompanied by exaggerated autonomic activation.
This is particularly the case with anxiety and stress, which
coincides with enhanced sympathetic tone, and decreased vagus
parasympathetic tone (Gianaros et al., 2012). Challenges to a
patient’s emotional, mental and physiological state similarly
evokes an alteration in sympathovagal balance, and a state of
physiological arousal, which is proposed to have a central role
in the propensity for seizures in epilepsy (Nagai and Critchley,
2008), or tics in Tourette Syndrome (Wood et al., 2003). In
turn, both the predisposition to and occurrence of seizures
and tic activity can inversely impair autonomic regulation.
Autonomic dysfunction leading to cardiac and respiratory arrest
may be a significant contributor to Sudden Unexpected Death
in Epilepsy (SUDEP) (Surges et al., 2009). Moreover, reduced
heart rate variability, an index of diminished “cardioprotective”
parasympathetic tone, is reported in patients with epilepsy
compared to healthy controls (Persson et al., 2007), increasing
vulnerability to cardiac arrest from arrhythmia. Thus in epilepsy,
there is evidence for association between SUDEP and autonomic
imbalance.
There is less evidence regarding the contribution of
autonomic function in patients with Tourette Syndrome.
An exaggerated initial heart rate acceleration during the Valsalva
Manuever test (van Dijk et al., 1992) and a higher baseline heart
rate and blood pressure (Tulen et al., 1998) in Tourette patients
compared with healthy controls has been reported. Considering
that genetic mutations cause both epilepsy and TS (Price et al.,
1985; Robertson, 2000), a link between these mutations and
autonomic function is of research interest.
Autonomic afferents are unmyelinated fibers originating from
visceral organs, skin, and skeletal muscles. The information
they carry is relevant to homeostasis (governed through both
peripheral reflexes and central pathways) and contributes
to autonomic, endocrine regulation, non-painful and painful
visceral sensations (Janig, 2006). Visceral autonomic signals also
shape emotional behaviors and arguably underpin emotional
feeling states through conscious appraisal of changes signaled
at a cortical level. Afferent neural pathways follow spinal
and cranial nerves (principally the vagus nerve, Janig, 2006).
Ascending spinal and vagus nerve afferents converge and
terminate within the lower and upper brain stem, hypothalamus
and thalamus. Vagal afferents enter the nucleus tract solitarius
(NTS), then project through to the ventromedial part of the
thalamus with spinal afferents and project to terminate as a
primary interoceptive cortical representation within the insula
cortex (Janig, 2006; Craig, 2009). Co-lateral thalamic projections
also include to the primary and secondary somatosensory
cortex (responsible for exteroception) and to the mid and
anterior cingulate cortex (responsible for motivation behavior
and interoception) (Janig, 2006; Craig, 2009). Importantly, this
ascending viscerosensory information also interacts at multiple
levels within the brainstem with both ascending and descending
monoamine systems that mediate peripheral sympathetic activity
and central arousal and attention (Critchley and Harrison, 2013).
The reticular activating system, and its effects on thalamocortical
information flow is particularly relevant, since it is speculated
that thalamic sensitivity to the signaling of autonomic afferent
arousal is a potent trigger of seizures and tics (Nagai et al., 2004c;
Nagai and Critchley, 2008).
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In an animal model of epilepsy (the Kainic acid model),
progressive neuronal loss in the NTS and SUDEP like death
is reported in rodents (Tolstykh and Cavazos, 2013). The
loss of neurons in the NTS is directly attributed to frequent
epileptic seizures (Tolstykh and Cavazos, 2013). Microinjection
of a cholinergic agonist (carbachol) into the thalamus also
elicits limbic and generalized seizures in rat (Mraovitch and
Calando, 1999). The detailed observation of seizure behavior,
and the timecourse of brain activity changes using identification
of c-fos early gene activity revealed the immediate effect of
an epileptogenic agent in regions of autonomic system such
as parabrachical nucleus and hypothalamus, indicating the
involvement of autonomic brain areas in the early stages of
seizure activity. The recruitment of limbic areas and thalamo-
cortical communication occurs later, around 60min after
injection (Mraovitch and Calando, 1999).
Animal models of Tourette Syndrome are rather fewer in
number. However, alpha 1 adrenergic drug administration has
been used to model tics (startle inhibition) in rat, and indicate
a role of autonomic agents in the neural mechanism underlying
Tourette Syndrome (Swerdlow et al., 2006).
The following model illustrates how emotional stimuli may
trigger epileptic seizures (Figure 1). Emotional disturbances can
originate from sensory stimulation such as vision, hearing, and
also from internal thoughts and memories. Whether or not such
information predictably recruits autonomic activation depends
on the intensity of stimulation, the significance of the timing
and individual differences in sensitivity and salience to stimuli
(Bauscein, 2006). Certain types of stimuli may preferentially
engage autonomic systems (e.g., disturbing thoughts changing
heart rate variability, Ottaviani et al., 2015). It is speculated
that these visceral afferent influences affect neural excitability
around seizure foci through effects mediated at the level of the
reticular formation and thalamus. Indeed, in a model of complex
partial seizures, a “Network Inhibition Hypothesis” proposes that
impaired consciousness is attributed to suppression of midline
subcortical structures (i.e., the reticular activation system).
Spreading seizure activity affects the reticular activation system
which leads to regional depression of frontoparietal association
cortex known to be crucial for maintenance of consciousness
(Blumenfeld, 2011). It is hypothesized that changes in thalamo-
cortical regulation impacts on seizure threshold via physiological
arousal and visceral feedback (Nagai, 2011). The typical
emotional and behavioral triggers of seizures (stress, sleep
deprivation, and fatigue) represent events that commonly disturb
autonomic regulation. In cognitive behavioral terms, disrupted
autonomic regulation in turn affects perception and cognition,
potentially creating a vicious circle in a patient’s emotional state.
Looking at autonomic dysregulation from a different angle,
seizure events themselves also affect autonomic activity: post ictal
autonomic dysregulation is one candidate as a cause for SUDEP
(Poh et al., 2012). Thus, autonomic dysregulation, reflecting
interaction between underlying brain pathology (e.g., temporal
lobe damage), seizure activity, the effect of anti-epileptic drugs
and the psychosocial consequences of societal conditioning and
stigma is inherently linked to the emotional resilience and
vulnerability of patients. Patients with epilepsy have specific
predisposing psychological and neural dynamics which underlie
seizure generation (Ridsdale et al., 2013).
Similarly, psychological influences and autonomic
dysfunction may also play a role in the expression of tics in
TS, through thalamo-cortical-striatal dysregulation [known
to underlie tic activity (Wang et al., 2011)]. Attempting to
alter these complex dynamics by modifying physiological and
psychological processes may represent a valuable treatment
option (Figure 2).
FIGURE 1 | Model of behavioral modulation and seizure generation. The model describespsychological and neural interaction influencing seizure generation.
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FIGURE 2 | Model of biofeedback intervention to behavioral modulation and seizure suppression. The model describes biofeedback intervention to alter
psychological and neural dynamics influencing seizure generation.
Modulation of Autonomic Activity as a
Treatment for Epilepsy and Tourette
Syndrome
While pharmacological approaches can be used to modulate
autonomic activity, the enhancement of autonomic control
(and its integration with other psychological and motoric
functions) can be achieved clinically using electrodermal
biofeedback (Nagai et al., 2004a,b). Biofeedback is a non-invasive
intervention with which patients can be trained to control
their physiological responses (Shwartz and Olson, 1995). A
variety of physiological parameters are accessible for biofeedback
however electrodermal activity (EDA) is typically an easy-to-
implement autonomic parameter, which exclusively modulates
sympathetic activity coupled to central psychological arousal.
Electrodermal activity (EDA) reflects peripheral sympathetic
nervous influences on sweat gland function, and is achieved
by applying a small electrical current to the skin surface, to
quantify changes in electrical resistance or conductance. The
sympathetic innervation of sweat glands is uniquely cholinergic,
hence unlike other effector organs with adrenergic/noradrenergic
sympathetic innervation, activity is not sensitive to humoral
monoaminergic levels. The measurement of EDA is a useful and
sensitive physiological measurement of emotional and mental
arousal, and is widely used in experimental conditions (Bauscein,
2006).
EDA biofeedback as a treatment for epilepsy is a relatively new
approach. However early evidence for its efficacy is promising
and suggests great potential for this psychophysiological
technique to become more available as an easy-to-implement
and side-effect free treatment. Nagai et al. (2004a) conducted
a preliminary randomized-controlled trial with 18 patients
with drug resistant epilepsy. Patients were trained to increase
their sympathetic activity through visual and auditory feedback
of their EDA activity. The treatment consisted of a half an
hour session, three times a week for 4 weeks. The results
demonstrated significant seizure reduction in the biofeedback-
active group, with over half these patient showing more than
50% seizure reduction after a month of EDA biofeedback
training (Nagai et al., 2004a) (Figure 3A). Accompanying
electroencephalography (EEG) recording showed baseline
changes in an experimental measure of cortical excitability:
the Contingent Negative Variation (CNV: an experimentally-
induced slow cortical potential), suggesting EDA biofeedback
induces long-term functional changes within neural networks
underpinning cortical excitation (Nagai et al., 2009). This
observed effect of EDA biofeedback was sustainable: a subset
of patients voluntarily kept a seizure diary for a much longer
term (over 3 years after treatment) and these records suggesting
that the treatment may prompt long term neurobiological
changes that maintain efficacy in seizure control (Nagai
and Trimble, 2014). The clinical trial findings were recently
replicated and showed similar results to the initial clinical trial
(Micoulaud-Franchi et al., 2014).
The effect of EDA biofeedback training has also been
examined in patients with Tourette Syndrome (Nagai et al.,
2008, 2014). In contrast with the application of EDA arousal
biofeedback in epilepsy, a preliminary study with patients with
Tourette Syndrome showed that the reduction of patients’
tics correlated with decreasing sympathetic activity (Nagai
et al., 2008) (Figure 3B). However, the clinical application
of EDA biofeedback for this patient group needs cautious
consideration. Standard training procedures established for other
conditions are much harder to implement in this patient
group, due to an apparent difficulty in reducing sympathetic
activity within this clinical population (Nagai et al., 2014).
Interestingly, this further supports the notion of autonomic
dysregulation in association with Tourette Syndrome. The
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A B
FIGURE 3 | Biofeedback intervention on Epilepsy and Tourette Syndrome. (A) Data from a randomized controlled trial in epilepsy patients. Six patients
out of 10 patients in biofeedback showed more than 50% seizure reduction after a month of EDA biofeedback intervention. Asterisk (*) show patients who
dropped out in the middle of the training. (B) Effect of peripheral autonomic modulation in patients with Tourette Syndrome. EDA biofeedback was
performed to increase and decrease skin conductivity. The number of tics occurring during 5min of bio-feedback intervention are presented for each
patient. (Nagai et al., 2004b, 2008, permission obtained).
FIGURE 4 | Brain activity modulated by the CNV amplitude. Neural
activities associated with CNV generation. The observed regions during the
CNV task include bilateral thalamus, ante- rior cingulate, SMA, pons, and
cerebellum. A fixed-effect analysis was used (p < 0.05, cor- rected). (Nagai
et al., 2004c, permission obtained).
presence of intermittent tics, and arguably the preceding “urge
to tic,” make it particularly difficult for patients to successfully
learn, perform and sustain EDA “relaxation” biofeedback with
typical training schedules (Nagai et al., 2014). However, tic
activity is reduced over short periods of EDA biofeedback that
suppress sympathetic activity (Nagai et al., 2009), and this
motivates further exploration for translation into an effective
intervention.
Neural Mechanisms of Autonomic Control
in Suppression of Seizures and Tics
EDA biofeedback is an easy-to-implement, potent and reliable
means of modulating autonomic activity. However, the detailed
neural mechanisms by which seizures are suppressed by EDA
biofeedback are still under investigation. A plausible explanation
of the clinical effect of EDA in epilepsy includes changes
in thalamo-cortical regulation leading to an increased seizure
threshold across the cortex. The modulation of cortical potentials
by EDA biofeedback may be important in reducing seizure
susceptibility in patients. The association of seizure activity with
slow cortical potentials is reinforced by the observation that
paroxysmal ictal activity is often accompanied by a negative DC
potential shift (direct current shift toward negative amplitude)
in patients (Chatrian et al., 1968). In animal models, a localized
cortical negative potential is also produced by chemical induction
(generalized seizure elicited by intraperitoneal or interavenous
pentylenetetrazol) of focal epilepsy (Casper and Speckman,
1972). Experimentally, slow cortical potentials can be induced
using a behavioral paradigm, a forewarned reaction time task,
that generates the CNV. A negative electrical DC shift is
measurable over the midline cortical area during the anticipatory
period between the presentation of a warning cue (to “get-
ready”) and an imperative stimulus (to respond). The cortical
excitability over this period is accompanied by enhanced central
arousal and action-related preparatory autonomic adjustments.
Changes in peripheral EDA activity modulate CNV amplitude,
whereby the magnitude of the slow cortical potential was
inversely related to the state of EDA measures of sympathetic
arousal (Nagai et al., 2004b). This observation in fact motivated
the therapeutic application of EDA “arousal” biofeedback (i.e.,
training to increase sympathetic EDA) as a means to decrease
cortical excitation in epilepsy.
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A neuroimaging study was conducted in healthy participants
to identify brain regions involved in the generation of the CNV:
on a trial-by-trial basis, CNV correlated with enhancement
of activity within the thalamus, anterior cingulate and
supplementary motor area (SMA), revealing the thalmo-cortical
network ultimately responsible for generation of the CNV
(Nagai et al., 2004c) (Figure 4). A parallel neuroimaging study
also revealed brain regions engaged during EDA biofeedback.
Activation within the ventro-medial prefrontal cortex (VMPFC)
and adjacent medical orbitofrontal cortex (OFC) were linearly,
yet inversely, correlated with the level of skin conductance
during EDA biofeedback (Nagai et al., 2004d) (Figure 5). Thus
increased EDA sympathetic arousal following biofeedback task
performance resulted in a decrease in the activation of VMPFC
and medial OFC, while biofeedback-induced decreases in EDA
levels resulted in an enhanced activation of these regions.
Interestingly, the VMPFC and medial OFC are both involved in
viscerosensory and form an important hub within the default
mode network, which deactivates during states of behavioral
arousal. Arguably the functional manipulation of the reactivity
of this brain region over a month of EDA biofeedback training
may, for patients with epilepsy, enhance the degree to which
thalamo-cortical excitability, and its gating by the ascending
reticular activating system, is suppressed during behavioral
arousal. The functional impairment of this network, reported in
patients with epilepsy, may be normalized, ultimately leading to
decreased vulnerability to internal and external seizure triggers.
In the case of Tourette Syndrome and related tic disorders, the
training to diminish levels of physiological arousal may help
increase the threshold for tics through the interaction between
A
C
B
FIGURE 5 | Regional brain activity associated with decrease in skin conductance level. (Nagai et al., 2004d, permission obtained). (A) Regional
brain activity related to task-independent decreases in skin conductance level (SCL). Decreases in SCL were associated with increased activity in VMPFC
and OFC. (P < 0.05, corrected). During the EDA biofeedback, activity in VMPFC and OFC is decreased. (B) Regional brain activity associated with
decreases in skin conductance level common across all subjects (P < 0.05, corrected). Common brain activity was found in VMPFC and OFC. (C) Plots of
individual subjects data showing correlations between skin conductance and ventromedial and orbitofrontal BOLD activity during biofeedback relaxation
(green dots) and arousal tasks (red dots). There was a significant negative correlation between adjusted VMPFC and OFC BOLD responses and
task-independent SCL activity in the eight subjects.
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motor pathways and autonomic central command. Alternatively,
the relationship with premonitory urges and compulsive
behavior may be an important mechanism: damage to the
viscerosensory insula cortex is observed to inhibit addictive
urges and compulsions to smoke (Gray and Critchley, 2007;
Naqvi and Bechara, 2009). Arguably, biofeedback “relaxation”
training can decrease viscerosensory arousal signals that underlie
or reinforce the feelings of urge and compulsions. This effect
may be mediated by the cortical representation of the arousal
state within default mode and salience networks, which in turn
influence motor excitability and ascending monoaminergic
pathways. While this provides a neurobiological model, there
needs to be further work in extending and translating current
knowledge of autonomic interaction with tics.
Conclusion
The role of autonomic nervous system activity in many
neurological conditions, including movement disorders, has
not been systematically investigated, yet compelling examples
exist, some presented here, of how autonomic function
bridges psychological and physical states to influence symptom
expression. In the current manuscript, a general principle is
illustrated for two neurological conditions, epilepsy and Tourette
Syndrome. However, the insights into the role of autonomic
function in the expression of clinical symptoms and presentation
may usefully extend to other neurological and neuropsychiatric
disorders. These observations allow us to begin to construct
theoretical models for experimental and translational science,
ultimately to provide novel or individualized interventions to
improve patients’ physiological and psychological condition. It is
proposed that autonomic biofeedback is a valuable therapeutic
tool, the potential of which has yet to be fully realized. In a
wider clinical trial, it is also important to investigate different
subtypes of seizures and tics, as the effectiveness of autonomic
modulation, and vulnerability to emotional challenges, may
present differently. It is anticipated that biofeedback can be
used to enhance the emotional and physiological stability of
patients with direct beneficial consequences for neurological
symptoms.
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